Excited to share our latest publication on the management of oral tox. secondary to targeted therapy in patients with cancer MASCC International Society of Oral Oncology (ISOO) Baptist Health FIU Medicine ADA link.springer.com/article/10.100…

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on prevention of osteonecrosis due to adjuvant bone modifying agents in primary breast cancer patients Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on the management of oral manifestations of chronic graft-versus-host-disease Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

Save the date for the MASCC/ISOO 2025 Annual Meeting from June 26 – 28, 2025 in Seattle, Washington, USA! Abstract submissions will open in September 2024. Learn more: annualmeeting.mascc.org #MASCC25 #SuppOnc

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on the risk of secondary oral cancer following hematopoietic cell transplantation Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on clinical assessment of salivary gland hypofunction and xerostomia in cancer patients Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on management of salivary gland hypofunction and xerostomia in cancer patients, Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

MASCC/ISOO Oral Care Study Group has published a Clinical Practice Statement (CPS) on management of oral complications of targeted therapy Springer Nature in Supportive Care in Cancer. Read and share here: link.springer.com/article/10.100…

“Adjuvant BP therapy is used in patients with non-metastatic breast cancer. This study aims to provide risk-mitigating strategies in the dental management of these patients in order to prevent MRONJ.” Read more: link.springer.com/article/10.100…

“In the absence of formal MASCC/ISOO guidelines, this CPS is the optimal road map to the management of oral manifestations of cGVHD.” Read more: link.springer.com/article/10.100…

“In patients with suspected oral lesions in the presence of oral mucosal cGVHD, an intervention for oral cGVHD may be considered to differentiate the chronic disease from oral cancer.” Read more: link.springer.com/article/10.100…

“Toothbrushing and proficient interproximal cleaning should not be discouraged during HCT.” Read more: link.springer.com/article/10.100…

“The correlation between salivary gland hypofunction and xerostomia is poor. Therefore, not all patients with xerostomia demonstrate the clinical signs and symptoms of salivary gland hypofunction and vice versa.” Read more: link.springer.com/article/10.100…

“The information presented in this CPS offers clinicians convenient access to the dosages and regimens of different interventions for managing salivary gland hypofunction or xerostomia.” Read more: link.springer.com/article/10.100…

“Proper description of the oral adverse effects will help with the diagnosis and direct the treatment accordingly. Clinicians are advised to be aware that some oral adverse effects may have symptoms without apparent abnormal findings.” Read more: link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients-prevention of medication-related osteonecrosis of the jaw, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: Management of oral manifestations of chronic graft-versus-host-disease, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…